Novartis

Novartis

Novartis

We provide healthcare solutions that address the evolving needs of patients & societies worldwide. See our community guidelines on our site
Type
B2b
Founded
1996
Follow us
Alexa global traffic share
Twitter followers
Team Size
5000+
Employees
Location
Headquarters
Fast Company

Novartis CEO: A vaccine will not magically save us from COVID-19

VentureBeat

Major pharma companies including Novartis and Merck build federated learning platform for drug discovery

VentureBeat

Major pharma companies, including Novartis and Merck, build federated learning platform for drug discovery

VCCircle

KKR ropes in former top Novartis exec in JB Chemicals board revamp

Fast Company

Novartis CEO Vas Narasimhan always keeps a fossil in his bag

Xconomy

Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D

MedCity News

Novartis agrees to pay $729M to settle kickback lawsuit

BetaKit

AccessNow wins $250,000 USD Novartis Prize for its accessibility platform

Bloomberg Technology

Novartis CEO Says Covid-19 Vaccine May Take Until End of 2021

Xconomy

Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation

VCCircle

Aurobindo Pharma’s $1-bn deal with Novartis unit Sandoz collapses

Pulse 2.0

Novartis, Life Sciences Consortium, And Gates Foundation Collaborate On COVID-19

Pulse 2.0

Novartis Sets Up $20 Million COVID-19 Response Fund

Xconomy

Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod

the home of AI info

Novartis pins hope on data science, AI for drug discovery

the home of AI info

Novartis, one of the world’s largest drugmakers, is turning to AI and data science to reinvent its …

SiliconANGLE

Novartis embraces the digital world to reimagine medicine for patients

VCCircle

Cipla acquires India trademark rights for anti-diabetic drug from Novartis

SiliconANGLE

BP shifts 900 workloads to AWS as Novartis, FINRA spin up new cloud data projects

Xconomy

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B